Guardado en:
| Autor principal: | Mamoor, Shahan |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2025
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.15312037 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SHPK.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: MINPP1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: WNK3.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: CXXC5.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: FJX1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: HOXB6.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: RPL19.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PFKFB4.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: DUT.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: ATG13.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GPSM3.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYH14.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MIR6732.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: FBXO21.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MMRN1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: LILRA4.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: CAPN15.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: HMGB3.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: ULK1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: KLF12.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DICER1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: PPME1.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Ejemplares similares
-
Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
por: Mamoor, Shahan
Publicado: (2025) -
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
por: Mamoor, Shahan
Publicado: (2025) -
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
por: Mamoor, Shahan
Publicado: (2025) -
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
por: Mamoor, Shahan
Publicado: (2025) -
Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)